Extracorporeal membrane oxygenation (ECMO) does not impact on amikacin pharmacokinetics: a case-control study

Intensive Care Med. 2016 May;42(5):946-948. doi: 10.1007/s00134-016-4267-x. Epub 2016 Mar 24.

E Gélisse^{1

2}, M Neuville², E de Montmollin³, L Bouadma^{2

4}, B Mourvillier², J F Timsit^{2

4}, R Sonneville^{5

6}

¹ Department of Intensive Care Medicine, CHU Reims, Reims, France.
² Department of Intensive Care Medicine and Infectious Diseases, Hôpital Bichat-Claude-Bernard, Assistance Publique Hôpitaux de Paris AP-HP, 46 rue Henri Huchard, 75018, Paris, France.
³ Department of Intensive Care Medicine, CH Saint Denis Delafontaine, Saint-Denis, France.
⁴ IAME U1137, Decision Science in Infectious Diseases, INSERM, Université Paris Diderot, Sorbonne Paris Cité, Paris, France.
⁵ Department of Intensive Care Medicine and Infectious Diseases, Hôpital Bichat-Claude-Bernard, Assistance Publique Hôpitaux de Paris AP-HP, 46 rue Henri Huchard, 75018, Paris, France. [email protected].
⁶ LVTS U1148, INSERM, Université Paris Diderot, Sorbonne Paris Cité, Paris, France. [email protected].

No abstract available

Publication types